| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.36 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |